Early Glycemic Control and Magnitude of HbA 1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators.

MLA

Svensson, Elisabeth, et al. “Early Glycemic Control and Magnitude of HbA 1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators.” Diabetes Care, vol. 40, no. 6, June 2017, pp. 800–07. EBSCOhost, https://doi.org/10.2337/dc16-2271.

APA

Svensson, E., Baggesen, L. M., Johnsen, S. P., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Thomsen, R. W. (2017). Early Glycemic Control and Magnitude of HbA 1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators. Diabetes Care, 40(6), 800–807. https://doi.org/10.2337/dc16-2271

Chicago

Svensson, Elisabeth, Lisbeth M Baggesen, Søren P Johnsen, Lars Pedersen, Helene Nørrelund, Esben S Buhl, Christiane L Haase, and Reimar W Thomsen. 2017. “Early Glycemic Control and Magnitude of HbA 1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators.” Diabetes Care 40 (6): 800–807. doi:10.2337/dc16-2271.